Disclosure: The author has a short position in one or more of the shares mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Earlier this month Haydale Graphene (HAYD) released an announcement with the headline: Haydale Awarded Funding to Develop Airbus Approved Space Technology, in which a contract awarded by the European Space Agency was proudly proclaimed. The size of both the funding and the contract were not disclosed as is usually the case with these trifling disclosures and the Haydale share price (sub 2p) scarcely moved, leaving its market cap little changed at around £5 million. It struck me, however, that had Versarien (VRS) - market cap £167 million - made an identical RNS the market cap would probably have risen, at least temporarily, by several times that of Haydale’s total worth, such is the fervour that the company still inspires amongst its loyal retail following. But the point at which Versarien must start to deliver is approaching...
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.